B. Braun Melsungen AG
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Subsidiary
- Established
- 1839-01-01
- Employees
- 10K
- Market Cap
- -
Clinical Trials
66
Active:21
Completed:40
Trial Phases
5 Phases
Phase 1:12
Phase 2:1
Phase 3:10
+2 more phases
Drug Approvals
105
CIMA_AEMPS:49
NMPA:27
PHILIPPINES:12
+3 more agencies
Drug Approvals
ω-3-Fish Oil Medium and Long Chain Fat Emulsion Injection
- Product Name
- ω-3鱼油中/长链脂肪乳注射液
- Approval Number
- 国药准字HJ20140970
- Approval Date
- Jun 28, 2024
NMPA
ω-3-Fish Oil Medium and Long Chain Fat Emulsion Injection
- Product Name
- ω-3鱼油中/长链脂肪乳注射液
- Approval Number
- 国药准字HJ20140969
- Approval Date
- Jun 28, 2024
NMPA
Propofol Medium and Long Chain Fat Emulsion Injection
- Product Name
- 丙泊酚中/长链脂肪乳注射液
- Approval Number
- 国药准字HJ20160354
- Approval Date
- May 6, 2021
NMPA
Propofol Medium and Long Chain Fat Emulsion Injection
- Product Name
- 丙泊酚中/长链脂肪乳注射液
- Approval Number
- 国药准字HJ20160353
- Approval Date
- May 6, 2021
NMPA
Propofol Medium and Long Chain Fat Emulsion Injection
- Product Name
- 丙泊酚中/长链脂肪乳注射液
- Approval Number
- 国药准字HJ20160427
- Approval Date
- May 6, 2021
NMPA
Propofol Medium and Long Chain Fat Emulsion Injection
- Product Name
- 丙泊酚中/长链脂肪乳注射液
- Approval Number
- 国药准字HJ20160352
- Approval Date
- May 6, 2021
NMPA
Etomidate Injectable Emulsion
- Product Name
- 依托咪酯乳状注射液
- Approval Number
- HJ20160234
- Approval Date
- Mar 15, 2021
NMPA
Etomidate Medium and Long Chain Fat Emulsion Injection
- Product Name
- 宜妥利
- Approval Number
- 国药准字HJ20160234
- Approval Date
- Mar 15, 2021
NMPA
Medium and Long Chain Fat Emulsion Injection(C8-24Ve)
- Product Name
- 力保肪宁
- Approval Number
- H20140834
- Approval Date
- Dec 17, 2019
NMPA
Medium and Long Chain Fat Emulsion/Amino Acids(16)/Glucose(16%) Injection
- Product Name
- 中长链脂肪乳/氨基酸(16)/葡萄糖(16%)注射液
- Approval Number
- H20140711
- Approval Date
- Oct 23, 2019
NMPA
- Prev
- 1
- 2
- 3
- Next
Clinical Trials
Distribution across different clinical trial phases (41 trials with phase data)• Click on a phase to view related trials
Phase 1
12 (29.3%)Not Applicable
10 (24.4%)Phase 3
10 (24.4%)Phase 4
8 (19.5%)Phase 2
1 (2.4%)Evaluation of Performance Over Dwell Time and Safety of the Central-venous Catheters Certofix® Paed
Completed
- Conditions
- Central Venous Catheter
- First Posted Date
- 2021-11-18
- Last Posted Date
- 2024-06-13
- Lead Sponsor
- B. Braun Melsungen AG
- Target Recruit Count
- 100
- Registration Number
- NCT05124821
- Locations
- 🇩🇪
Medizinische Hochschule Hannover, Klinik für Pädiatrische Kardiologie und Pädiatrische Intensivmedizin, Hannover, Germany
🇮🇹Istituto Giannina Gaslini, Anesthesia and Acute and Procedural Pain Therapy, Genova, Italy
🇮🇹Ospedale de Bambini Vittore Buzzi, Milano, Italy
Differences in Exhaled Breath by Using Ion Mobility Spectrometry (IMS) in Subjects Tested for SARS-CoV-2 Infection (COVID-19 Disease)
Completed
- Conditions
- SARS (Severe Acute Respiratory Syndrome)Covid19
- First Posted Date
- 2020-12-02
- Last Posted Date
- 2021-05-03
- Lead Sponsor
- B. Braun Melsungen AG
- Target Recruit Count
- 450
- Registration Number
- NCT04649931
- Locations
- 🇩🇪
University Hospital Gießen and Marburg (UKGM), site Marburg, Marburg, Germany
Comparison Between Propofol Concentration in Exhaled Breath and Blood Plasma Using the Exhaled Drug Monitor "Edmon"
Not Applicable
Withdrawn
- Conditions
- Elective Surgical ProceduresAnesthesia, Intravenous
- First Posted Date
- 2020-10-14
- Last Posted Date
- 2021-06-03
- Lead Sponsor
- B. Braun Melsungen AG
- Registration Number
- NCT04586998
Identification of Differences in Breath Components Detected With IMS in Patients Tested on SARS-CoV-2 (COVID-19)
Completed
- Conditions
- Covid19
- First Posted Date
- 2020-09-21
- Last Posted Date
- 2021-07-08
- Lead Sponsor
- B. Braun Melsungen AG
- Target Recruit Count
- 396
- Registration Number
- NCT04556318
- Locations
- 🇩🇪
Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany
🇩🇪Technical University of Munich, Klinikum rechts der Isar, Munich, Germany
SeQuent® SCB "All Comers" Post Market Clinical Follow-up (PMCF)
Active, not recruiting
- Conditions
- Coronary Artery DiseaseMyocardial Ischaemia
- First Posted Date
- 2020-07-14
- Last Posted Date
- 2025-01-15
- Lead Sponsor
- B. Braun Melsungen AG
- Target Recruit Count
- 1302
- Registration Number
- NCT04470934
- Locations
- 🇩🇪
Universitätsklinikum Jena, Jena, Thüringen, Germany
- Prev
- 1
- 2
- 3
- 4
- 5
- 10
- Next
News
No news found